DISSECT will develop strategies for SARS therapy and prophylaxis, in the first instance for health workers and later for other vulnerable groups.
The project aims to:
· Study and compare various potential vaccine approaches, including ‘classical’ vaccines (based on whole inactivated virus), subunit vaccines, and recombinant vaccines.
· Develop antiviral therapies
· Generate diagnostic kits to identify infected individuals at early stages of the disease, and differentiate between naturally infected and immunised patients